The landscape of American healthcare stands at a critical crossroads as the debate over physician-owned hospitals (POHs) intensifies, carrying profound implications for access, equity, and financial stability across the sector. With over 150 rural hospitals closed since 2010 and many more on the
Introduction to Diabetes Care Innovations In a world where over 38 million Americans live with diabetes, the quest for effective, user-friendly management tools has never been more critical, especially as the burden of daily insulin injections and complex treatment regimens often deters patients
Overview of a Shifting Landscape In 2025, the landscape of U.S. immigration policy stands at a critical juncture, with proposed changes to public charge rules under the Trump administration sparking intense debate across communities and industries. A staggering statistic from the 2025 KFF/New York
Today, we’re diving into the complex world of biosimilar drugs and regulatory challenges with Faisal Zain, a renowned healthcare expert specializing in medical technology. With his extensive background in the manufacturing of medical devices for diagnostics and treatment, Faisal brings a unique p
Could a single drug approval redefine access to treatment for a rare, life-altering condition? In a landscape where high costs often limit hope for patients with familial chylomicronemia syndrome (FCS), Arrowhead Pharmaceuticals has ignited a spark of change with its FDA-approved RNAi drug,
Understanding the Telehealth Landscape The telehealth sector in the U.S. healthcare system has witnessed unprecedented growth, transforming how care is delivered amid rising demand and persistent challenges. With millions of patients now accessing medical services remotely, telehealth has become a
